Policy and Advocacy News 3
Policy and Advocacy News
-
Ruling Against PrEP Access Sets Dangerous Precedent
amfAR strongly condemns a ruling by a federal judge in Texas that restricts free insurance coverage of PrEP, a biomedical HIV prevention tool.
-
Lighting Fires, Creating Change
At AIDS 2022, researchers, policy makers, and advocates fought to keep the momentum going in the fight for HIV and healthcare access and equity.
-
On Dangerous Ground
“In Danger”, a new UNAIDS report about the global HIV response, warns that progress has stalled in light of new infections and AIDS-related deaths.
-
Monkeypox: Time Is of the Essence
amfAR and the O’Neill Institute have issued a policy brief on monkeypox urging action to prevent further spread of the disease.
-
amfAR at AIDS 2022
Researchers from amfAR and the foundation’s partners will present on community-led HIV programming at the 24th International AIDS Conference
-
The Supreme Court’s Calamitous Decision
amfAR condemns the repeal of Roe v. Wade, which denies people the right to abortion and creates barriers to HIV and other sexual health services.
-
Response to ICAP’s Critique of “Blinded by Our Own Data”
amfAR’s Public Policy Office responds to ICAP’s critique of its report on PEPFAR’s HIV recency testing program, “Blinded by Our Own Data”.
-
Blinded By Our Own Data
PEPFAR’s recency testing-based approach to identify and target HIV transmission “hot-spots” suffers from severe limitations, says amfAR in new report.
-
In Memoriam: Urvashi Vaid
amfAR mourns the passing of attorney Urvashi Vaid, an LGBTQ activist dedicated to civil rights, anti-war efforts, health justice, and HIV/AIDS.
-
amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event
amfAR vice president and director of public policy Greg Millett took part in a World AIDS Day program sponsored by the Smithsonian’s National Museum of Natural History on December 3, 2020. Millett spoke in a segment covering laws and policies affecting people with HIV.
-
Biden Releases Updated National HIV/AIDS Strategy
At a World AIDS Day event at the White House, President Biden announced the release of an updated National HIV/AIDS Strategy and recommitted the United States to ending AIDS as a public health threat by 2030.
-
Stark Inequities Continue to Undermine U.S. HIV Response
Unequal access to prevention and care, stigma drive worrying trends for Black and Latino gay men.
-
FDA Approves Long-Acting Injectable to Treat HIV
A long-acting-acting HIV treatment consisting of two shots monthly has been approved by the U.S. Food & Drug Administration (FDA) for adults with suppressed virus currently on a stable antiretroviral regimen.
-
amfAR’s Greg Millett Presents on 40th Anniversary of HIV/AIDS
amfAR vice president and director of public policy Greg Millett took part in a virtual webinar and conversation with senior federal officials and community leaders on the 40th anniversary of HIV/AIDS on Tuesday, June 15, 2021. Greg discussed how HIV has changed the world, and similarities between COVID-19 and HIV.
-
U.S. Sees Progress on HIV, Room for Improvement
A series of reports released by the Centers for Disease Control and Prevention (CDC), May 27, show “hopeful signs of progress” but point to some areas in which progress continues to lag. The reports, which use CDC surveillance data, all cover the five-year period 2015 to 2019.